Cerebral amyloid angiopathy-related hemorrhage

Interaction of APOE ε2 with putative clinical risk factors

Mark O. McCarron, James A R Nicoll, James W. Ironside, Seth Love, Mark J. Alberts, Ian Bone

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Background and Purpose - Current evidence suggests that the apolipoprotein E (APOE for gene; apoE for protein) ε4 allele predisposes to cerebral amyloid angiopathy (CAA) whereas ε2 is associated with CAA-related hemorrhage (CAAH). The clinical risk factors for other forms of intracranial hemorrhage are a less-frequent feature of CAAH. In this study we examined potential clinical risk factors in patients with CAAH and assessed these with respect to APOE genotype. Methods - Thirty-six patients were identified with a pathological diagnosis of CAAH. Clinical notes were reviewed to document age of hemorrhage onset, history of dementia, antiplatelet/anticoagulant medication, hypertension, minor head trauma, or transient neurological events. In a review of reported cases of CAAH, the frequency of these clinical features was also recorded. APOE genotypes were determined with use of polymerase chain reaction techniques. Results - There were 24 women and 12 men; the mean age was 70.3 years. One third (n=12) had been taking antiplatelet medication, and a similar number were demented. Nine patients were hypertensive, and 4 had a history of recent minor head trauma. The relative frequency of each of these clinical features was similar to that in previous reports. Forty-four percent (16 of 36) possessed an ε2 allele. Antiplatelet or anticoagulant medication, hypertension, or minor head trauma were significantly more frequent antecedents of CAAH in ε2 carriers than in non-ε2 carriers (81% versus 35%, P=0.008), antiplatelet/anticoagulant medication in particular (P=0.038). Conclusions - Our findings suggest that antiplatelet or anticoagulant medication, hypertension, or minor head trauma are most likely to precipitate cerebral hemorrhage in patients with CAA who are also ε2 carriers. This may result from isoform-specific effects of apoE on the structure of amyloid-laden blood vessel walls.

Original languageEnglish (US)
Pages (from-to)1643-1646
Number of pages4
JournalStroke
Volume30
Issue number8
StatePublished - Aug 1999

Fingerprint

Cerebral Amyloid Angiopathy
Hemorrhage
Craniocerebral Trauma
Anticoagulants
Apolipoproteins E
Hypertension
Alleles
Genotype
Intracranial Hemorrhages
Cerebral Hemorrhage
Age of Onset
Amyloid
Blood Vessels
Dementia
Protein Isoforms
Polymerase Chain Reaction

Keywords

  • Apolipoproteins
  • Cerebral amyloid angiopathy
  • Intracerebral hemorrhage

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

McCarron, M. O., Nicoll, J. A. R., Ironside, J. W., Love, S., Alberts, M. J., & Bone, I. (1999). Cerebral amyloid angiopathy-related hemorrhage: Interaction of APOE ε2 with putative clinical risk factors. Stroke, 30(8), 1643-1646.

Cerebral amyloid angiopathy-related hemorrhage : Interaction of APOE ε2 with putative clinical risk factors. / McCarron, Mark O.; Nicoll, James A R; Ironside, James W.; Love, Seth; Alberts, Mark J.; Bone, Ian.

In: Stroke, Vol. 30, No. 8, 08.1999, p. 1643-1646.

Research output: Contribution to journalArticle

McCarron, MO, Nicoll, JAR, Ironside, JW, Love, S, Alberts, MJ & Bone, I 1999, 'Cerebral amyloid angiopathy-related hemorrhage: Interaction of APOE ε2 with putative clinical risk factors', Stroke, vol. 30, no. 8, pp. 1643-1646.
McCarron, Mark O. ; Nicoll, James A R ; Ironside, James W. ; Love, Seth ; Alberts, Mark J. ; Bone, Ian. / Cerebral amyloid angiopathy-related hemorrhage : Interaction of APOE ε2 with putative clinical risk factors. In: Stroke. 1999 ; Vol. 30, No. 8. pp. 1643-1646.
@article{82ea73ba8355412db7d1e080b2737003,
title = "Cerebral amyloid angiopathy-related hemorrhage: Interaction of APOE ε2 with putative clinical risk factors",
abstract = "Background and Purpose - Current evidence suggests that the apolipoprotein E (APOE for gene; apoE for protein) ε4 allele predisposes to cerebral amyloid angiopathy (CAA) whereas ε2 is associated with CAA-related hemorrhage (CAAH). The clinical risk factors for other forms of intracranial hemorrhage are a less-frequent feature of CAAH. In this study we examined potential clinical risk factors in patients with CAAH and assessed these with respect to APOE genotype. Methods - Thirty-six patients were identified with a pathological diagnosis of CAAH. Clinical notes were reviewed to document age of hemorrhage onset, history of dementia, antiplatelet/anticoagulant medication, hypertension, minor head trauma, or transient neurological events. In a review of reported cases of CAAH, the frequency of these clinical features was also recorded. APOE genotypes were determined with use of polymerase chain reaction techniques. Results - There were 24 women and 12 men; the mean age was 70.3 years. One third (n=12) had been taking antiplatelet medication, and a similar number were demented. Nine patients were hypertensive, and 4 had a history of recent minor head trauma. The relative frequency of each of these clinical features was similar to that in previous reports. Forty-four percent (16 of 36) possessed an ε2 allele. Antiplatelet or anticoagulant medication, hypertension, or minor head trauma were significantly more frequent antecedents of CAAH in ε2 carriers than in non-ε2 carriers (81{\%} versus 35{\%}, P=0.008), antiplatelet/anticoagulant medication in particular (P=0.038). Conclusions - Our findings suggest that antiplatelet or anticoagulant medication, hypertension, or minor head trauma are most likely to precipitate cerebral hemorrhage in patients with CAA who are also ε2 carriers. This may result from isoform-specific effects of apoE on the structure of amyloid-laden blood vessel walls.",
keywords = "Apolipoproteins, Cerebral amyloid angiopathy, Intracerebral hemorrhage",
author = "McCarron, {Mark O.} and Nicoll, {James A R} and Ironside, {James W.} and Seth Love and Alberts, {Mark J.} and Ian Bone",
year = "1999",
month = "8",
language = "English (US)",
volume = "30",
pages = "1643--1646",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Cerebral amyloid angiopathy-related hemorrhage

T2 - Interaction of APOE ε2 with putative clinical risk factors

AU - McCarron, Mark O.

AU - Nicoll, James A R

AU - Ironside, James W.

AU - Love, Seth

AU - Alberts, Mark J.

AU - Bone, Ian

PY - 1999/8

Y1 - 1999/8

N2 - Background and Purpose - Current evidence suggests that the apolipoprotein E (APOE for gene; apoE for protein) ε4 allele predisposes to cerebral amyloid angiopathy (CAA) whereas ε2 is associated with CAA-related hemorrhage (CAAH). The clinical risk factors for other forms of intracranial hemorrhage are a less-frequent feature of CAAH. In this study we examined potential clinical risk factors in patients with CAAH and assessed these with respect to APOE genotype. Methods - Thirty-six patients were identified with a pathological diagnosis of CAAH. Clinical notes were reviewed to document age of hemorrhage onset, history of dementia, antiplatelet/anticoagulant medication, hypertension, minor head trauma, or transient neurological events. In a review of reported cases of CAAH, the frequency of these clinical features was also recorded. APOE genotypes were determined with use of polymerase chain reaction techniques. Results - There were 24 women and 12 men; the mean age was 70.3 years. One third (n=12) had been taking antiplatelet medication, and a similar number were demented. Nine patients were hypertensive, and 4 had a history of recent minor head trauma. The relative frequency of each of these clinical features was similar to that in previous reports. Forty-four percent (16 of 36) possessed an ε2 allele. Antiplatelet or anticoagulant medication, hypertension, or minor head trauma were significantly more frequent antecedents of CAAH in ε2 carriers than in non-ε2 carriers (81% versus 35%, P=0.008), antiplatelet/anticoagulant medication in particular (P=0.038). Conclusions - Our findings suggest that antiplatelet or anticoagulant medication, hypertension, or minor head trauma are most likely to precipitate cerebral hemorrhage in patients with CAA who are also ε2 carriers. This may result from isoform-specific effects of apoE on the structure of amyloid-laden blood vessel walls.

AB - Background and Purpose - Current evidence suggests that the apolipoprotein E (APOE for gene; apoE for protein) ε4 allele predisposes to cerebral amyloid angiopathy (CAA) whereas ε2 is associated with CAA-related hemorrhage (CAAH). The clinical risk factors for other forms of intracranial hemorrhage are a less-frequent feature of CAAH. In this study we examined potential clinical risk factors in patients with CAAH and assessed these with respect to APOE genotype. Methods - Thirty-six patients were identified with a pathological diagnosis of CAAH. Clinical notes were reviewed to document age of hemorrhage onset, history of dementia, antiplatelet/anticoagulant medication, hypertension, minor head trauma, or transient neurological events. In a review of reported cases of CAAH, the frequency of these clinical features was also recorded. APOE genotypes were determined with use of polymerase chain reaction techniques. Results - There were 24 women and 12 men; the mean age was 70.3 years. One third (n=12) had been taking antiplatelet medication, and a similar number were demented. Nine patients were hypertensive, and 4 had a history of recent minor head trauma. The relative frequency of each of these clinical features was similar to that in previous reports. Forty-four percent (16 of 36) possessed an ε2 allele. Antiplatelet or anticoagulant medication, hypertension, or minor head trauma were significantly more frequent antecedents of CAAH in ε2 carriers than in non-ε2 carriers (81% versus 35%, P=0.008), antiplatelet/anticoagulant medication in particular (P=0.038). Conclusions - Our findings suggest that antiplatelet or anticoagulant medication, hypertension, or minor head trauma are most likely to precipitate cerebral hemorrhage in patients with CAA who are also ε2 carriers. This may result from isoform-specific effects of apoE on the structure of amyloid-laden blood vessel walls.

KW - Apolipoproteins

KW - Cerebral amyloid angiopathy

KW - Intracerebral hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=0032770330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032770330&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 1643

EP - 1646

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 8

ER -